Cepheid develops molecular diagnostic systems that deliver fast, accurate test results when and where they matter most. The GeneXpert platform automates complex PCR testing, making it accessible beyond traditional laboratories. With tests spanning respiratory infections, tuberculosis, sexual health, oncology, and emerging diseases, Cepheid enables healthcare professionals to make informed decisions swiftly. Operating in over 180 countries as part of Danaher Corporation, Cepheid addresses critical gaps in global healthcare access. The Global Access Program ensures high quality diagnostic testing reaches underserved communities worldwide. Every test helps clinicians detect infections earlier and save lives through timely intervention.
4690
Team Members
1996
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where every person, everywhere has access to fast, accurate molecular diagnostic testing that enables early disease detection and timely treatment for better health outcomes.
At Cepheid, our mission is to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
Loading open positions…
Join our team! Explore current opportunities at Cepheid.